OTCMKTS:ERRFY Eurofins Scientific (ERRFY) Stock Price, News & Analysis $11.99 +1.99 (+19.90%) As of 05/11/2021 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Eurofins Scientific Stock (OTCMKTS:ERRFY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Eurofins Scientific alerts:Sign Up Key Stats Today's Range$11.99▼$11.9950-Day Range$11.99▼$11.9952-Week Range$3.03▼$30.00Volume100 shsAverage Volume12,799 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewEurofins Scientific SE engages in the bio-analytical testing of food, environment, and pharmaceuticals products. The firm offers testing and laboratory services for agro science, genomics, discovery pharmacology and for supporting clinical studies. It operates through the following geographical segments: Europe, North America, and Rest of the World. The company was founded by Gilles G. Martin in 1987 and is headquartered in Luxembourg.Read More… Receive ERRFY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Eurofins Scientific and its competitors with MarketBeat's FREE daily newsletter. Email Address ERRFY Stock News HeadlinesEurofins Scientific SE (ERFSF) Q2 2025 Earnings Call TranscriptApril 23, 2025 | seekingalpha.comTemu boosts product safety and compliance with Eurofins partnershipApril 8, 2025 | msn.comRecession Fears Mounting? 2 AI Stocks to Watch Now2025 is off to a turbulent start—markets are swinging wildly, inflation pressures remain high, and recession fears are creeping back into headlines. But even in uncertain times, innovation doesn’t slow down. In fact, artificial intelligence (AI) is accelerating faster than ever—creating new profit opportunities while the broader market struggles. Our latest research reveals two AI stocks trading under $15 that could thrive even as volatility grows. These under-the-radar companies are positioned to ride the next wave of AI-driven demand—and they’re still flying below most investors’ radar.June 3, 2025 | Darwin (Ad)Temu Partners With Eurofins to Shore Up Product Safety and ComplianceApril 8, 2025 | msn.comEurofins targets 6.5% organic growth through 2027 with margin optimizationJanuary 30, 2025 | msn.comThe Noise Has Been Loud Lately, But At The Deepest Level Eurofins Is UnchangedJanuary 30, 2025 | seekingalpha.comKepler Capital Keeps Their Buy Rating on Eurofins Scientific (0MV5)November 16, 2024 | markets.businessinsider.comKepler Capital Sticks to Its Buy Rating for Eurofins Scientific (0MV5)October 6, 2024 | markets.businessinsider.comSee More Headlines ERRFY Stock Analysis - Frequently Asked Questions How have ERRFY shares performed this year? Eurofins Scientific's stock was trading at $11.99 at the start of the year. Since then, ERRFY stock has increased by 0.0% and is now trading at $11.99. View the best growth stocks for 2025 here. How do I buy shares of Eurofins Scientific? Shares of ERRFY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Services To The Health Industry Sub-IndustryN/A Current SymbolOTCMKTS:ERRFY CIKN/A WebN/A Phone(522) 618-5320FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (OTCMKTS:ERRFY) was last updated on 6/3/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredThe Social Security Changes No One’s Talking AboutWhile most Americans worry about their next Social Security check... something far bigger is happening behind ...Altimetry | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | Sponsored“You all just got a lot richer”Trump Knows What He’s Doing. When the president says he’s going to let RFK “go wild” … and Big Pharma crash...Brownstone Research | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eurofins Scientific SE Please log in to your account or sign up in order to add this asset to your watchlist. Share Eurofins Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
